Point72 Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,200
Closed -$1.09M 4005
2025
Q3
$1.09M Buy
16,200
+1,100
+7% +$73K ﹤0.01% 1670
2025
Q2
$984K Buy
+15,100
New +$905K ﹤0.01% 1564
2023
Q1
Sell
-6,700
Closed -$501K 2370
2022
Q4
$501K Hold
6,700
﹤0.01% 1150
2022
Q3
$432K Hold
6,700
﹤0.01% 1189
2022
Q2
$464K Buy
+6,700
New +$497K ﹤0.01% 1201
2018
Q3
Sell
-300,000
Closed -$11.9M 1087
2018
Q2
$11.9M Buy
+300,000
New +$11.5M 0.05% 403
2016
Q3
Sell
-55,500
Closed -$1.92M 774
2016
Q2
$1.92M Buy
+55,500
New +$1.92M 0.01% 571

Other funds holding HOLX

Point72 Asset Management's HOLX Position: Q1 2026 in Review

Point72 Asset Management reduced its Hologic (HOLX) stake by 65% in Q1 2026, selling an estimated $10.2M and leaving 71,776 shares worth $5.43M. The position accounts for 0.01% of the portfolio, ranked #1650.

Point72 Asset Management first reported a position in HOLX in Q3 2015 and has held it in 28 quarters since. The position peaked at $132M in Q3 2023. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Point72 Asset Management held 71,776 shares of Hologic worth $5.43M as of Q1 2026.
  • Point72 Asset Management sold 136,269 Hologic shares in Q1 2026, an estimated $10.2M.
  • Hologic made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1650 holding.
  • Point72 Asset Management first reported a position in Hologic in Q3 2015 and has held it in 28 quarters since.
  • Point72 Asset Management's Hologic position peaked at $132M in Q3 2023.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.